Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma

Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) are the most common forms of aggressive and indolent lymphoma, respectively. The majority of patients are cured by standard R-CHOP immunochemotherapy, but 30%–40% of DLBCL and 20% of FL patients relapse or are refractory (R/R). DLBCL...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuckey, Ruth, Luzardo Henríquez, Hugo, de la Nuez Melian, Haridian, Rivero Vera, José Carlos, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134203/
https://www.ncbi.nlm.nih.gov/pubmed/37124135
http://dx.doi.org/10.5306/wjco.v14.i4.160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134203/
https://www.ncbi.nlm.nih.gov/pubmed/37124135
http://dx.doi.org/10.5306/wjco.v14.i4.160

Ejemplares similares